Fact based stock research
West Pharmaceutical Services (NYSE:WST)


West Pharmaceutical Services stock research in summary

westpharma.com


West Pharmaceutical Services shares have a HOLD rating. While they are safely financed, they show below average growth, and are bad value. We recommend holding West Pharmaceutical Services shares.


Latest Obermatt Ranks


Value Rank 34
Growth Rank 36
Safety Rank 65
Combined Rank 43
Country USA
Industry Health Care Supplies
Index S&P MIDCAP, D.J. US Medical Equipment
Size class Medium

October 12, 2018. Top 10 stocks updated on Top 10 schedule or at least quarterly. ()


☀ Achievements

Top 10 Stock

Google: West Pharmaceutical Services

News

Videos

Wikipedia about West Pharmaceutical Services

Management

Employee Satisfaction

Customer Satisfaction

Similar Stocks
All Top 10 Lists
Free Stock Update

Research History: West Pharmaceutical Services

RESEARCH HISTORY 2015 2016 2017 2018
VALUE
VALUE 40
29
23
34
GROWTH
GROWTH 36
96
40
36
SAFETY
SAFETY 73
69
95
65
COMBINED
COMBINED 31
71
76
43

Last update of Combined Rank: 12-Oct-2018. Stock research history is based on the Obermatt Method. The higher the rank, the better West Pharmaceutical Services is in the corresponding investment strategy.


Value Metrics in Detail

VALUE METRICS 2015 2016 2017 2018
PRICE VS. REVENUES (P/S)
PRICE VS. REVENUES (P/S) 29
18
19
18
PRICE VS. PROFITS (P/E)
PRICE VS. PROFITS (P/E) 41
38
37
42
PRICE VS. CAPITAL (Market-to-Book)
PRICE VS. CAPITAL (Market-to-Book) 37
26
22
18
DIVIDEND YIELD
DIVIDEND YIELD 54
56
54
62
CONSOLIDATED RANK: VALUE
CONSOLIDATED RANK: VALUE 40
29
23
34

Last update of Value Rank: 12-Oct-2018. Stock analysis on value ratios: The higher the rank, the lower the value ratio of West Pharmaceutical Services; except for dividend yield where the rank is higher, the higher the yield.


Growth Metrics in Detail

GROWTH METRICS 2015 2016 2017 2018
REVENUE GROWTH
REVENUE GROWTH 35
65
34
43
PROFIT GROWTH
PROFIT GROWTH 43
43
43
40
STOCK RETURNS
STOCK RETURNS 54
95
55
50
CONSOLIDATED RANK: GROWTH
CONSOLIDATED RANK: GROWTH 36
96
40
36

Financial reporting date of Growth Rank: 30-Jun-2018. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of West Pharmaceutical Services.


Safety Metrics in Detail

SAFETY METRICS 2015 2016 2017 2018
LEVERAGE
LEVERAGE 50
50
58
59
REFINANCING
REFINANCING 27
26
28
27
LIQUIDITY
LIQUIDITY 92
95
97
94
CONSOLIDATED RANK: SAFETY
CONSOLIDATED RANK: SAFETY 73
69
95
65

Financial reporting date of Safety Rank: 30-Jun-2018. Stock analysis on safety metrics: The higher the rank, the lower the leverage of West Pharmaceutical Services and the more cash is available to service its debt.


Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for West Pharmaceutical Services from October 12, 2018.